NCT04071444 is a NA clinical trial of Baduanjin program in Randomized Controlled Trial, sponsored by National Yang Ming Chiao Tung University.

Who is sponsoring NCT04071444?

NCT04071444 is sponsored by National Yang Ming Chiao Tung University.

What drugs are being tested in NCT04071444?

Interventions in NCT04071444: Baduanjin program.

What condition does NCT04071444 study?

NCT04071444 studies Randomized Controlled Trial.

Is NCT04071444 still recruiting?

NCT04071444 is currently completed. Last updated 9 September 2020.

Last reviewed 2020-09-09 · How we verify

NCT04071444

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploring the Effects of a Baduanjin Program on the Symptoms of Constipation in Patients With Schizophrenia Spectrum

Completed NA Last updated 9 September 2020

What this trial tests

NA trial testing Baduanjin program in Randomized Controlled Trial in 112 participants. Completed in 1 July 2019.

Timeline

8 October 2018

Primary endpoint
1 July 2019

1 July 2019

Quick facts

Lead sponsor	National Yang Ming Chiao Tung University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	112
Start date	8 October 2018
Primary completion	1 July 2019
Estimated completion	1 July 2019
Sites	1 location across Taiwan

Drugs / interventions tested

Baduanjin program

Conditions studied

Randomized Controlled Trial — all drugs for Randomized Controlled Trial →

Sponsor

National Yang Ming Chiao Tung University

Who can join

Adults 20 to 64, any sex, with Randomized Controlled Trial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with schizophrenia spectrum have been suffering from constipation due to long-term use of psychotropic medications and changes in physical activity and eating habits caused by diseases. Aim this study was to examine the effectiveness of Baduanjin program in improving the symptoms of intestinal peristalsis and constipation in patients with psychosis. Method:A randomized controlled trial was conducted in tow psychiatric centers in northern Taiwan.The experimental group was provided with an 8- session Baduanjin program for 24 weeks (1 hour, thrice times per week), while the control group received routine care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Randomized Controlled Trial

Currently open trials in the same condition.

NCT07382830 — Effectiveness of a Visual Feedback Exercise Program Following Lumbar Surgery · NA · recruiting
NCT07226700 — Suzetrigine in Total Hip Arthroplasty · Phase 3 · recruiting
NCT07461467 — Effects of Continuous Monitoring and Progressive Regulation of Inflatable Laryngeal Mask Airway Cuff Pressure on Postope · NA · recruiting
NCT07143773 — SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients · Phase 4 · recruiting
NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy · NA · recruiting

Other National Yang Ming Chiao Tung University trials

Trials by the same sponsor.

NCT07448857 — Kinematics and Muscle Activation of Scapula in Upper String Players With Neck Pain · recruiting
NCT07318454 — Comparison of Abdominal Expansion and Abdominal Drawing-In Training With Manual and Verbal Cueing in Chronic Non-Specifi · NA · not yet recruiting
NCT07494461 — Inhibitory Control and Gait Adaptability in Parkinson's Disease · not yet recruiting
NCT07494487 — Reliability of Community Ambulation Ability, Fall Risk, and Dynamic Visual Acuity Assessments in Stroke · not yet recruiting
NCT07494500 — Vestibular Training on Community Ambulation and Fall Risk in Stroke · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04071444 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Yang Ming Chiao Tung University
Last refreshed: 9 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04071444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing